aMoon

By Dave Muoio 12:17 pm June 26, 2019
DayTwo, an Israeli company that analyzes gut microbiomes to assist with nutrition and glycemic control, has raised $31 million in Series B financing. Ofek Ventures and aMoon led the round, with additional support coming from prior backers Seventure Partners and Johnson & Johnson. With this, the company brings its total backing to $48 million. WHAT THEY DO DayTwo’s platform asks patients to...